Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002071876-25-000050
Filing Date
2025-09-23
Accepted
2025-09-23 16:06:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 6045
  Complete submission text file 0002071876-25-000050.txt   7584
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Subject) CIK: 0001356090 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-88073 | Film No.: 251333685
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O APG LLC ONE SOUTH STREET, SUITE 2550 BALTIMORE MD 21202
Business Address
Miller William H III (Filed by) CIK: 0001783044 (see all company filings)

Type: SCHEDULE 13G